Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
- PMID: 4397663
- PMCID: PMC2139037
- DOI: 10.1084/jem.134.1.83
Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
Abstract
Mice are capable of rejecting H-2-incompatible bone marrow grafts after a single lethal exposure to X-rays. The onset of rejection begins 18-24 hr after transplantation and is completed by 96 hr. Maturation of this type of allograft reactivity does not occur until the 22nd day of life. In adult mice, the resistance to marrow allografts can be weakened by administration of cyclophosphamide or dead cultures of Corynebacterium parvum, but not heterologous anti-thymocyte serum. Sublethal exposures to X-rays 7 or 14 days before transplantation also weaken resistance. There is considerable interstrain variation in the ability of mice to resist allografts, even when H-2 differences between hosts and donor are kept identical. Although H-2 incompatibility is a necessary prerequisite for resistance, additional genetic factors influence the outcome of marrow allografts, presumably by controlling recognition. The regulator genes are determinant specific and the alleles for resistance or responder status appear to be dominant. The responder phenotype is expressed by hemopoietic cells and not by the environment. Accordingly, resistance is conferred to otherwise susceptible mice upon transfer of bone marrow cells but not of serum. The production and differentiation of effector cells for marrow graft rejection are thymus independent. In conclusion, bone marrow allografts elicit a particular transplantation reaction, previously unknown, in irradiated mice. Peculiar features of this reaction are the lack of proliferation of host lymphoid cells, tissue specificity, thymus independence, and regulation by genetic factors which apparently do not affect the fate of other grafts.
Similar articles
-
Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.J Exp Med. 1971 Dec 1;134(6):1513-28. doi: 10.1084/jem.134.6.1513. J Exp Med. 1971. PMID: 4942407 Free PMC article.
-
Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains.J Exp Med. 1971 Jul 1;134(1):281-93. doi: 10.1084/jem.134.1.281. J Exp Med. 1971. PMID: 4934149 Free PMC article.
-
Long-term survival of cardiac allografts in lethally irradiated rats repopulated with host-type hemopoietic cells.Transplantation. 1975 Apr;19(4):295-301. doi: 10.1097/00007890-197504000-00004. Transplantation. 1975. PMID: 239473
-
Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.Exp Hematol. 1977 May;5(3):215-35. Exp Hematol. 1977. PMID: 326573 Review. No abstract available.
-
The double barrier in bone marrow transplantation.Semin Hematol. 1974 Jul;11(3):325-40. Semin Hematol. 1974. PMID: 4151846 Review. No abstract available.
Cited by
-
Bone marrow graft rejection as a function of antibody-directed natural killer cells.J Exp Med. 1985 Mar 1;161(3):563-76. doi: 10.1084/jem.161.3.563. J Exp Med. 1985. PMID: 2579185 Free PMC article.
-
The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).J Clin Immunol. 2007 Jan;27(1):109-16. doi: 10.1007/s10875-006-9058-7. Epub 2006 Dec 27. J Clin Immunol. 2007. PMID: 17191149
-
Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.J Exp Med. 1984 Apr 1;159(4):1132-48. doi: 10.1084/jem.159.4.1132. J Exp Med. 1984. PMID: 6368735 Free PMC article.
-
Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.Biol Blood Marrow Transplant. 2008 Oct;14(10):1088-1099. doi: 10.1016/j.bbmt.2008.08.001. Biol Blood Marrow Transplant. 2008. PMID: 18804038 Free PMC article.
-
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.Leukemia. 2015 Aug;29(8):1754-62. doi: 10.1038/leu.2015.75. Epub 2015 Mar 16. Leukemia. 2015. PMID: 25772027 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources